Ordinance
on Clinical Trials
with the exception of
Clinical Trials of Medical Devices¹
(Clinical Trials Ordinance, ClinO)

¹ The spon­sor and the in­vest­ig­at­or, and the oth­er per­sons in­volved in the clin­ic­al tri­al, shall main­tain sci­entif­ic in­teg­rity. In par­tic­u­lar, it is pro­hib­ited:

a.

to falsi­fy, fab­ric­ate or sup­press re­search res­ults;

b.

to fail to dis­close con­flicts of in­terest at the plan­ning stage, in the ap­prov­al pro­ced­ure, or when con­duct­ing or pub­lish­ing re­search;

c.

to im­pede or pre­vent re­search activ­it­ies without good reas­on;

d.

to pre­vent or sanc­tion the ex­pos­ure of sci­entif­ic mis­con­duct.

² The code of con­duct for sci­entif­ic in­teg­rity, is­sued by the Swiss Academies of Arts and Sci­ences, as spe­cified in An­nex 1 num­ber 1, is ap­plic­able. In jus­ti­fied cases, oth­er re­cog­nised sci­entif­ic in­teg­rity guidelines of equi­val­ent stand­ing may be used.²³